By Agence France-Presse
Tuesday, January 21, 2014 17:41 EST
Consumers may expect that medical treatments approved for the US market are safe and thoroughly tested, but a study out Tuesday said that is not always the case.
Some drugs undergo more rigorous testing than others, while most are never compared to existing treatments to see if they are better or worse, said the study by researchers at Yale University.
The study in the Journal of the American Medical Association reviewed the process by which 188 new therapies were accepted for US market by the Food and Drug Administration over a seven-year span.
continue to read here
Tuesday, January 21, 2014 17:41 EST
Consumers may expect that medical treatments approved for the US market are safe and thoroughly tested, but a study out Tuesday said that is not always the case.
Some drugs undergo more rigorous testing than others, while most are never compared to existing treatments to see if they are better or worse, said the study by researchers at Yale University.
The study in the Journal of the American Medical Association reviewed the process by which 188 new therapies were accepted for US market by the Food and Drug Administration over a seven-year span.
continue to read here